Search Results - Herbert Struemper
- Showing 1 - 3 results of 3
-
1
Population pharmacokinetics of belantamab mafodotin, a BCMA‐targeting agent in patients with relapsed/refractory multiple myeloma by Chetan Rathi, Jon Collins, Herbert Struemper, Joanna Opalinska, Roxanne C. Jewell, Geraldine Ferron‐Brady
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Longitudinal efficacy and safety modeling and simulation framework to aid dose selection of belantamab mafodotin for patients with multiple myeloma by Jon Collins, Martijn vanNoort, Chetan Rathi, Teun M. Post, Herbert Struemper, Roxanne C. Jewell, Geraldine Ferron‐Brady
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Manufacturing‐dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development by Neeltje Steeghs, Aaron R. Hansen, Glenn J. Hanna, Elena Garralda, Haeseong Park, James Strauss, Michael Adam, Gossett Campbell, Jennifer Carver, Rachael Easton, Katherine Mays, Peter Skrdla, Herbert Struemper, Michael L. Washburn, Christopher Matheny, Sarina A. Piha‐Paul
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book